Passage Bio Inc (PASG)
1.50
+0.03
(+2.04%)
USD |
NASDAQ |
May 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Passage Bio Price to Book Value: 0.7494 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 0.7344 |
May 08, 2024 | 0.7494 |
May 07, 2024 | 0.7894 |
May 06, 2024 | 0.7045 |
May 03, 2024 | 0.6545 |
May 02, 2024 | 0.6695 |
May 01, 2024 | 0.6745 |
April 30, 2024 | 0.6445 |
April 29, 2024 | 0.6495 |
April 26, 2024 | 0.6595 |
April 25, 2024 | 0.6095 |
April 24, 2024 | 0.6195 |
April 23, 2024 | 0.6145 |
April 22, 2024 | 0.5696 |
April 19, 2024 | 0.5746 |
April 18, 2024 | 0.5995 |
April 17, 2024 | 0.6345 |
April 16, 2024 | 0.6195 |
April 15, 2024 | 0.6145 |
April 12, 2024 | 0.6695 |
April 11, 2024 | 0.6795 |
April 10, 2024 | 0.6295 |
April 09, 2024 | 0.6595 |
April 08, 2024 | 0.6745 |
April 05, 2024 | 0.7145 |
Date | Value |
---|---|
April 04, 2024 | 0.677 |
April 03, 2024 | 0.6745 |
April 02, 2024 | 0.6495 |
April 01, 2024 | 0.6845 |
March 28, 2024 | 0.6745 |
March 27, 2024 | 0.6545 |
March 26, 2024 | 0.6345 |
March 25, 2024 | 0.6745 |
March 22, 2024 | 0.6945 |
March 21, 2024 | 0.6845 |
March 20, 2024 | 0.7644 |
March 19, 2024 | 0.6995 |
March 18, 2024 | 0.7294 |
March 15, 2024 | 0.7494 |
March 14, 2024 | 0.6245 |
March 13, 2024 | 0.6345 |
March 12, 2024 | 0.6695 |
March 11, 2024 | 0.6995 |
March 08, 2024 | 0.7244 |
March 07, 2024 | 0.7994 |
March 06, 2024 | 0.8543 |
March 05, 2024 | 0.8394 |
March 04, 2024 | 0.8543 |
March 01, 2024 | 0.8444 |
February 29, 2024 | 0.8543 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2398
Minimum
Sep 29 2023
4.466
Maximum
Jan 14 2021
1.208
Average
0.6506
Median
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 1.774 |
Palatin Technologies Inc | -- |
iBio Inc | 0.7084 |
Theriva Biologics Inc | 0.1624 |
Oragenics Inc | 5.233 |
Price to Book Value Related Metrics
Price | 1.50 |
Earnings Yield | -124.0% |
Market Cap | 83.40M |